Analysis of haematological risk factors for thromboembolic events in anaemic cancer patients treated with epoetin beta

被引：0
|
作者：
Aapro, M.
Boogaerts, M.
Coiffier, B.
Hayward, C.
Burger, H.
机构：
[1] Clin Genolier, Inst Multidisciplinaire Oncol, Genolier, France
[2] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
[3] Ctr Hosp Lyon Sud, Lyon, France
[4] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：386 / 386
页数：1
相关论文
共 50 条
  • [41] Standards, Options:: Recommendations for the use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, darbepoetin) in anaemic patients with cancer:: 2007 update
    Ray-Coquard, I.
    Kassab-Chahmi, D.
    Casadevall, N.
    Chastagner, P.
    Marchal, C.
    Marec-Berard, P.
    Misset, J. -L.
    ONCOLOGIE, 2008, 10 (02) : 160 - 166
  • [42] Efficacy of epoetin beta 30,000 IU once weekly in anaemic patients with solid and non-myeloid haematological malignancies receiving chemotherapy
    Spaeth, D
    Mennecier, B
    Hammerer, V
    Barlési, F
    Fiorentini, P
    Bergougnoux, L
    LUNG CANCER, 2005, 49 : S396 - S396
  • [43] Statins, aspirin and risk of thromboembolic events in ovarian cancer patients
    Shai, Ayelet
    Rennert, Hedy S.
    Rennert, Gad
    Sagi, Shlomi
    Leviov, Michelle
    Lavie, Ofer
    GYNECOLOGIC ONCOLOGY, 2014, 133 (02) : 304 - 308
  • [44] Risk of Venous Thromboembolic Events in Patients With Cancer Treated With Aflibercept: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Kanukula, Raju
    Ganta, Shruthi
    Sirumalla, Yashaswee
    Salam, Abdul
    Baddam, Ravali
    Pasupuleti, Bhuvana C.
    AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (04) : E549 - E552
  • [45] Incidence and impact of thromboembolic events in lung cancer patients treated with nivolumab
    Hegde, Aparna Madhukeshwar
    Stroud, Chipman Robert Geoffrey
    Cherry, Cynthia R.
    Yogarajah, Meera
    Cherukuri, Sulochana Devi
    Walker, Paul R.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [46] IMPACT OF EPOETIN BETA ON EXECUTIVE FUNCTIONS IN ANAEMIC PATIENTS WITH BREAST CANCER RECEIVING CHEMOTHERAPY: RESULTS OF A PROSPECTIVE COHORT STUDY
    Pivot, X.
    Hugonot-Diener, L.
    Coscas, Y.
    Auquier, P.
    Castrec, E.
    Vlamynck, G.
    Bleuzen, P.
    Namer, M.
    Gligorov, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 396 - 396
  • [47] Risk factors for thromboembolic events in pediatric patients with ventricular assist devices
    Adderley, Jeremy
    Pidborochynski, Tara
    Buchholz, Holger
    Holinski, Paula
    Anand, Vijay
    Jonker, Izak De Villiers
    Freed, Darren H.
    Al-Aklabi, Mohammed
    Conway, Jennifer
    JTCVS OPEN, 2024, 20 : 132 - 140
  • [48] Inherited Risk Factors of Thromboembolic Events in Patients with Primary Nephrotic Syndrome
    Ismail, Gener
    Obrisca, Bogdan
    Jurubita, Roxana
    Andronesi, Andreea
    Sorohan, Bogdan
    Harza, Mihai
    MEDICINA-LITHUANIA, 2020, 56 (05):
  • [49] RISK FACTORS ASSOCIATED WITH THROMBOEMBOLIC EVENTS IN PEDIATRIC ALL/LL PATIENTS
    Ford, James
    Gothard, Dave
    Cockrell, Erin
    PEDIATRIC BLOOD & CANCER, 2011, 56 (06) : 918 - 918
  • [50] RISK FACTORS OF VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WITH RHEUMATHOID ARTHRITIS (RA)
    Satybaldyeva, M. A.
    Seredavkina, N. S.
    Glukhova, S.
    Karateev, D.
    Reshetnyak, T.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 710 - 710
12345